| Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection AF Pardiñas, P Holmans, AJ Pocklington, V Escott-Price, S Ripke, ... Nature genetics 50 (3), 381-389, 2018 | 1527 | 2018 |
| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1261 | 2022 |
| Impact of the Ultrarapid CYP2C19*17 Allele on Serum Concentration of Escitalopram in Psychiatric Patients I Rudberg, B Mohebi, M Hermann, H Refsum, E Molden Clinical Pharmacology & Therapeutics 83 (2), 322-327, 2008 | 302 | 2008 |
| The effect of variable cigarette consumption on the interaction with clozapine and olanzapine T Haslemo, PH Eikeseth, L Tanum, E Molden, H Refsum European journal of clinical pharmacology 62, 1049-1053, 2006 | 225 | 2006 |
| Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients MM Jukić, T Haslemo, E Molden, M Ingelman-Sundberg American Journal of Psychiatry 175 (5), 463-470, 2018 | 196 | 2018 |
| An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels J De Leon, G Schoretsanitis, RL Smith, E Molden, A Solismaa, N Seppälä, ... Pharmacopsychiatry 55 (02), 73-86, 2022 | 171 | 2022 |
| Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several‐fold in patients with atorvastatin‐induced myopathy M Hermann, MP Bogsrud, E Molden, A Åsberg, BU Mohebi, L Ose, ... Clinical Pharmacology & Therapeutics 79 (6), 532-539, 2006 | 169 | 2006 |
| Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study MM Jukic, RL Smith, T Haslemo, E Molden, M Ingelman-Sundberg The Lancet Psychiatry 6 (5), 418-426, 2019 | 159 | 2019 |
| Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial H Kersten, E Molden, IK Tolo, E Skovlund, K Engedal, TB Wyller Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2013 | 147 | 2013 |
| Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta-analysis F Milosavljević, N Bukvić, Z Pavlović, Č Miljević, V Pešić, E Molden, ... JAMA psychiatry 78 (3), 270-280, 2021 | 139 | 2021 |
| Impact of OATP1B1, MDR1, and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects M Ulvestad, IB Skottheim, GS Jakobsen, S Bremer, E Molden, A Åsberg, ... Clinical Pharmacology & Therapeutics 93 (3), 275-282, 2013 | 120 | 2013 |
| Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients I Rudberg, M Hermann, H Refsum, E Molden European journal of clinical pharmacology 64, 1181-1188, 2008 | 107 | 2008 |
| Side effect burden of antipsychotic drugs in real life–Impact of gender and polypharmacy TSJ Iversen, NE Steen, I Dieset, S Hope, R Mørch, ES Gardsjord, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 82, 263-271, 2018 | 105 | 2018 |
| Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients E Molden, H Lunde, N Lunder, H Refsum Therapeutic drug monitoring 28 (6), 744-749, 2006 | 101 | 2006 |
| Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5 GV Bakken, I Rudberg, H Christensen, E Molden, H Refsum, M Hermann Drug metabolism and disposition 37 (2), 254-258, 2009 | 100 | 2009 |
| Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole M Hendset, M Hermann, H Lunde, H Refsum, E Molden European journal of clinical pharmacology 63, 1147-1151, 2007 | 99 | 2007 |
| Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling … R Romskaug, E Skovlund, J Straand, E Molden, H Kersten, KH Pitkala, ... JAMA internal medicine 180 (2), 181-189, 2020 | 92 | 2020 |
| The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs M Hendset, T Haslemo, I Rudberg, H Refsum, E Molden Pharmacopsychiatry 39 (04), 121-127, 2006 | 84 | 2006 |
| Sex-dependent shared and nonshared genetic architecture across mood and psychotic disorders GAM Blokland, J Grove, CY Chen, C Cotsapas, S Tobet, R Handa, ... Biological psychiatry 91 (1), 102-117, 2022 | 83 | 2022 |
| Treatment with antipsychotics in pregnancy: changes in drug disposition AA Westin, M Brekke, E Molden, E Skogvoll, I Castberg, O Spigset Clinical Pharmacology & Therapeutics 103 (3), 477-484, 2018 | 81 | 2018 |
